CIA
KYMR icon

Cape Investment Advisory’s Kymera Therapeutics KYMR Stock Holding History

Cape Investment Advisory’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.23K Buy
+11
New +$1.26K ﹤0.01% 1325

Other funds holding KYMR

NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return

Cape Investment Advisory's KYMR Position: Q3 2026 in Review

Cape Investment Advisory opened a new position in Kymera Therapeutics (KYMR) in Q3 2026: 11 shares worth $1.23K. The stake represents ﹤0.01% of the portfolio and ranks #1325 among its holdings.

7 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

  • Cape Investment Advisory held 11 shares of Kymera Therapeutics worth $1.23K as of Q3 2026.
  • Kymera Therapeutics was a new Cape Investment Advisory position in Q3 2026.
  • Kymera Therapeutics made up ﹤0.01% of Cape Investment Advisory's portfolio in Q3 2026, its #1325 holding.
  • 7 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on Cape Investment Advisory's 13F filing for Q3 2026, filed 13 Oct 2026.